Please use this identifier to cite or link to this item:
|Title:||生技產業廠商之經營與發展策略分析 – 以G公司為例|
The Corporate Strategy Analysis of the Biotechnology Industry Company – A Case Study of G Company
nutritional supplement products,BCG matrix,Porter five forces analysis model,Competitive strategy,key industry factor,
|Publication Year :||2020|
Today, the aged society has become a worldwide issue. With highly developed information and communication technology as well as the advanced preventive healthcare, people in the developed countries have aware of the importance of personal health management and disease prevention. Varies nutritional supplement products for regulating physiological functions, delaying aging and increasing immunity have launched and triggered a vigorous growth in global health food market. The mainstream products in the health foods industry is for improving gastrointestinal function, regulating blood lipids, protecting liver and immune regulation. As most of products are limited to the categories for the food efficacy aforementioned, the inter-industry competition is cutthroat. Increasing product safety and efficacy have become the top index for each of companies in the industry.
In these couple years, the revenue of company G was sustained growth. Porter five forces analysis model is applied in this study to analysis the key industry factors of both Taiwan and mainland China health foods OEM market and the developed core value and competitive advantage of company G. Using BCG matrix for reviewing its product portfolio and competition position for each of business units as well as the future strategies of company G. The study results are summarized as below:
I. The key industry factor of company G’s two major business units in Taiwan are the vertical integration capabilities of upstream, midstream and downstream, the development of new technologies, the research and development capabilities of functional materials, and the strong direct sales and e-commerce sales capabilities.
II. Company G mainly adopts a low-cost leadership strategy. The three major businesses units can share resources and technical capabilities in the upstream and midstream, create comprehensive effects and build a complete competitive strategy, and create a unique one with complete industrial chain integration and business strategies, laying the groundwork of competitive advantage.
For company G’s long-term growth, it’s recommended
i. To increase and extend the patent categories of functional materials as well as focus on the development of patent portfolio.
ii. To analysis the data from members of direct selling and e-commerce with APPs and portable mobile devices, then create the personal and customized health care product consulting services.
|Appears in Collections:||生物科技管理碩士在職學位學程|
Files in This Item:
|3.34 MB||Adobe PDF|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.